Your browser doesn't support javascript.
loading
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study.
Cremolini, C; Morano, F; Moretto, R; Berenato, R; Tamborini, E; Perrone, F; Rossini, D; Gloghini, A; Busico, A; Zucchelli, G; Baratelli, C; Tamburini, E; Tampellini, M; Sensi, E; Fucà, G; Volpi, C; Milione, M; Di Maio, M; Fontanini, G; De Braud, F; Falcone, A; Pietrantonio, F.
Affiliation
  • Cremolini C; Unit of Medical Oncology 2, Department of Translational Research and New Technologies in Medicine and Surgery, Azienda Ospedaliera-Universitaria Pisana, University of Pisa, Pisa.
  • Morano F; Medical Oncology Department, IRCCS Istituto Nazionale dei Tumori, Milan.
  • Moretto R; Unit of Medical Oncology 2, Department of Translational Research and New Technologies in Medicine and Surgery, Azienda Ospedaliera-Universitaria Pisana, University of Pisa, Pisa.
  • Berenato R; Medical Oncology Department, IRCCS Istituto Nazionale dei Tumori, Milan.
  • Tamborini E; Laboratory of Experimental Molecular Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Perrone F; Laboratory of Experimental Molecular Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Rossini D; Unit of Medical Oncology 2, Department of Translational Research and New Technologies in Medicine and Surgery, Azienda Ospedaliera-Universitaria Pisana, University of Pisa, Pisa.
  • Gloghini A; Laboratory of Experimental Molecular Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Busico A; Laboratory of Experimental Molecular Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Zucchelli G; Unit of Medical Oncology 2, Department of Translational Research and New Technologies in Medicine and Surgery, Azienda Ospedaliera-Universitaria Pisana, University of Pisa, Pisa.
  • Baratelli C; Department of Oncology, University of Turin - Ordine Mauriziano Hospital, Turin.
  • Tamburini E; Department of Oncology, Ospedale Infermi, Rimini.
  • Tampellini M; Department of Oncology, Ospedale San Luigi, Orbassano.
  • Sensi E; Department of Surgical, Medical, Molecular Pathology and Critical Care, Università di Pisa, Pisa.
  • Fucà G; Medical Oncology Department, IRCCS Istituto Nazionale dei Tumori, Milan.
  • Volpi C; Laboratory of Experimental Molecular Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Milione M; Laboratory of Experimental Molecular Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Di Maio M; Department of Oncology, University of Turin - Ordine Mauriziano Hospital, Turin.
  • Fontanini G; Department of Surgical, Medical, Molecular Pathology and Critical Care, Università di Pisa, Pisa.
  • De Braud F; Medical Oncology Department, IRCCS Istituto Nazionale dei Tumori, Milan.
  • Falcone A; Department of Oncology and Hematoncology, University Of Milan, Milan, IRCCS Fondazione Istituto Nazionale dei Tumori, Milan, Italy.
  • Pietrantonio F; Unit of Medical Oncology 2, Department of Translational Research and New Technologies in Medicine and Surgery, Azienda Ospedaliera-Universitaria Pisana, University of Pisa, Pisa.
Ann Oncol ; 28(12): 3009-3014, 2017 Dec 01.
Article in En | MEDLINE | ID: mdl-29045518

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Colorectal Neoplasms / ErbB Receptors / Antibodies, Monoclonal Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Colorectal Neoplasms / ErbB Receptors / Antibodies, Monoclonal Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Year: 2017 Document type: Article